在术后恶心和吐上口香糖的有效性:系统性审查和元分析
Kuei-Lin Liao1, Hsiu-Hung Wang2, Li-Yu Yang2
1College of Nursing, Kaohsiung Medical University, Kaohsiung City, Taiwan; Department of Anesthesiology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
概括
在12项试验的元分析中,口香糖有效减少了手术后的吐. 较长的30分钟疗程在吐减少方面显示出更大的有效性,尽管恶心缓解并不显著.
科学领域:
- 医学研究 医学研究
- 临床干预措施 临床干预
- 基于证据的实践实践.
背景情况:
- 手术后的恶心和吐是患者常见的抱怨.
- 寻求非药物干预来管理这些症状.
- 口香糖是一个潜在的低风险选择.
研究的目的:
- 系统地评估口香糖在缓解术后恶心和吐方面的疗效.
- 综合关于这个主题的随机对照试验的发现.
主要方法:
- 在多个数据库中进行了全面的系统文献搜索.
- 随机试验的方法质量使用Cochrane风险偏见2.0工具进行了评估.
- 进行了一种固定效应模型元分析,将12项随机试验 (1458名参与者) 的数据汇集在一起.
主要成果:
- 口香糖显著减少了手术后的吐 (风险比率 = 0.55,P = .007).
- 没有观察到恶心显著减少 (风险比率 = 0.84,P = .14).
- 30分钟的口香糖会比15分钟的会话更有效地减少吐 (P = .04).
结论:
- 口香糖,特别是30分钟,可以作为一种可行的非药物方法来减少术后吐.
- 需要进一步的研究,以充分阐明口香糖干预措施的好处和最佳使用.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
205
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
205
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
292
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
292
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
279
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
279
Suctioning the Nasopharyngeal Airway
423
Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
Equipment Required
423
Pathophysiology of Vomiting
452
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
452


